Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 21070768)

1.

Subtyping of human cellular prion proteins and their differential solubility.

Kuczius T, Wohlers J, Karch H, Groschup MH.

Exp Neurol. 2011 Jan;227(1):188-94. doi: 10.1016/j.expneurol.2010.10.014. Epub 2010 Nov 9.

PMID:
21070768
2.

Cellular prion proteins in human platelets show a phenotype different to those in brain tissues.

Kuczius T, Kleinert J, Karch H, Sibrowski W, Kelsch R.

J Cell Biochem. 2011 Mar;112(3):954-62. doi: 10.1002/jcb.23012.

PMID:
21328470
3.

Differential solubility of prions is associated in manifold phenotypes.

Kuczius T, Karch H, Groschup MH.

Mol Cell Neurosci. 2009 Nov;42(3):226-33. doi: 10.1016/j.mcn.2009.07.004. Epub 2009 Jul 14.

PMID:
19607920
4.

Cellular prion proteins in humans and cattle but not sheep are characterized by a low-solubility phenotype.

Kuczius T, Groschup MH.

Comp Immunol Microbiol Infect Dis. 2013 Dec;36(6):599-605. doi: 10.1016/j.cimid.2013.07.004. Epub 2013 Aug 13.

PMID:
23948376
5.

Regional phenotypes of cellular prion proteins in human brains identified by differential detergent solubility.

Kuczius T, Groschup MH.

Brain Res. 2013 Apr 24;1507:19-27. doi: 10.1016/j.brainres.2013.02.034. Epub 2013 Feb 27.

PMID:
23454232
6.

Effects of metal binding on solubility and resistance of physiological prions depend on tissues and glycotypes.

Kuczius T, Kelsch R.

J Cell Biochem. 2013 Dec;114(12):2690-8. doi: 10.1002/jcb.24616.

PMID:
23794222
7.

Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.

Zanusso G, Farinazzo A, Prelli F, Fiorini M, Gelati M, Ferrari S, Righetti PG, Rizzuto N, Frangione B, Monaco S.

J Biol Chem. 2004 Sep 10;279(37):38936-42. Epub 2004 Jul 9.

8.

Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.

Zou WQ, Cashman NR.

J Biol Chem. 2002 Nov 15;277(46):43942-7. Epub 2002 Aug 2.

9.

Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.

Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, Raeber AJ, Aguzzi A.

Cell. 2003 Apr 4;113(1):49-60.

10.

Factors affecting interactions between prion protein isoforms.

Caughey B, Baron GS.

Biochem Soc Trans. 2002 Aug;30(4):565-9.

PMID:
12196138
11.

Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).

Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z.

J Neurochem. 2001 Mar;76(6):1654-62.

PMID:
11259483
12.

Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease.

Gilch S, Winklhofer KF, Groschup MH, Nunziante M, Lucassen R, Spielhaupter C, Muranyi W, Riesner D, Tatzelt J, Schätzl HM.

EMBO J. 2001 Aug 1;20(15):3957-66.

13.

The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.

Hetz C, Russelakis-Carneiro M, Wälchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C.

J Neurosci. 2005 Mar 16;25(11):2793-802.

14.

Regional and phenotype heterogeneity of cellular prion proteins in the human brain.

Kuczius T, Koch R, Keyvani K, Karch H, Grassi J, Groschup MH.

Eur J Neurosci. 2007 May;25(9):2649-55. Epub 2007 Apr 27.

PMID:
17466020
15.
16.

Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie.

Tatzelt J, Groth DF, Torchia M, Prusiner SB, DeArmond SJ.

J Neuropathol Exp Neurol. 1999 Dec;58(12):1244-9.

PMID:
10604749
17.

Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.

Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A.

Biochemistry. 2002 Oct 22;41(42):12868-75.

PMID:
12379130
18.

Aberrant metal binding by prion protein in human prion disease.

Wong BS, Chen SG, Colucci M, Xie Z, Pan T, Liu T, Li R, Gambetti P, Sy MS, Brown DR.

J Neurochem. 2001 Sep;78(6):1400-8.

PMID:
11579148
19.

Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.

Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, Tagliavini F, Monaco S, Caramelli M.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3065-70. Epub 2004 Feb 17.

20.

Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.

Bate C, Salmona M, Diomede L, Williams A.

J Biol Chem. 2004 Apr 9;279(15):14983-90. Epub 2004 Jan 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk